KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) EBT Margin (2019 - 2025)

Historic EBT Margin for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to 3.11%.

  • GoodRx Holdings' EBT Margin fell 10400.0% to 3.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.71%, marking a year-over-year increase of 72900.0%. This contributed to the annual value of 3.97% for FY2024, which is 113800.0% up from last year.
  • Per GoodRx Holdings' latest filing, its EBT Margin stood at 3.11% for Q3 2025, which was down 10400.0% from 9.64% recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' EBT Margin ranged from a high of 9.64% in Q2 2025 and a low of 25.9% during Q3 2023
  • Over the past 5 years, GoodRx Holdings' median EBT Margin value was 1.95% (recorded in 2023), while the average stood at 0.7%.
  • The largest annual percentage gain for GoodRx Holdings' EBT Margin in the last 5 years was 2018100bps (2021), contrasted with its biggest fall of -331100bps (2021).
  • GoodRx Holdings' EBT Margin (Quarter) stood at 2.75% in 2021, then crashed by -194bps to 2.58% in 2022, then tumbled by -386bps to 12.53% in 2023, then surged by 146bps to 5.75% in 2024, then tumbled by -46bps to 3.11% in 2025.
  • Its EBT Margin stands at 3.11% for Q3 2025, versus 9.64% for Q2 2025 and 8.21% for Q1 2025.